Dr. James Stevenson
Dr. James Stevenson is an oncologist and hematologist in Cleveland, Ohio. Dr. Stevenson works at the Cleveland Clinic and specializes in pleural mesothelioma treatment and research.
Dr. James Stevenson
Ohio Mesothelioma Doctor
Vice Chairman of the Department of Hematology and Medical Oncology
Jefferson Medical College of Thomas Jefferson University, 1992
Thomas Jefferson University Hospital, 1995
Thomas Jefferson University Hospital, 1998
Dr. James Stevenson works at the Taussig Cancer Institute at the Cleveland Clinic. Dr. Stevenson has more than 20 years of experience in thoracic oncology. This includes lung cancer and pleural mesothelioma care.
Dr. Stevenson works with a team of oncology specialists to diagnose and treat mesothelioma. As part of a multidisciplinary team, Dr. Stevenson helps support every patient’s unique situation.
Dr. Stevenson’s Professional History
Dr. James Stevenson began his medical training at Jefferson Medical College at Thomas Jefferson University. After graduating from medical school in 1992, he completed a one-year internship in internal medicine at the University of Florida College of Medicine.
Dr. Stevenson returned to Thomas Jefferson University to complete an internal medicine residency and fellowship. In 1998, he completed a three-year fellowship in hematology and medical oncology.
Dr. Stevenson later worked at Penn Presbyterian Medical Center and served as the Director of Thoracic Oncology. While at Penn, he also was involved in mesothelioma clinical trials. Specifically, Dr. Stevenson helped test the effectiveness of immunotherapy treatment.
In 2012, Dr. Stevenson joined the team at the Cleveland Clinic. He later became the Vice Chairman of the Department of Hematology and Medical Oncology in July of 2015.
Dr. Stevenson currently works at the Taussig Cancer Institute, serving cancer patients. He has more than 20 years of medical experience. Dr. Stevenson’s patients have said he is a knowledgeable and compassionate doctor.
Clinical Interests and Research
Dr. Stevenson is an expert in thoracic oncology and hematology. He has experience working with a variety of cancer patients, including those with lung cancer and mesothelioma.
Dr. Stevenson‘s Medical Areas of Interest
- Carcinoid tumors of the lungs
- Lung cancer
- Rare cancer and blood disease
- Thymic cancer
Dr. Stevenson and his team work with mesothelioma patients to develop a unique treatment plan. Treatment plans may include chemotherapy, radiation, surgery or palliative care. He also has an interest in immunotherapy treatment and clinical trials.
Through treatment, Dr. Stevenson works to provide symptom relief and improve overall life expectancy for patients.
Dr. Stevenson has studied the efficacy of immunotherapy and chemotherapy treatments in mesothelioma patients. He continues to be involved in mesothelioma research and ongoing clinical trials.
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study. The Lancet Oncology. November 2016;(11):1497-1508. doi: 10.1016/S1470-2045(16)30498-3.
Current issues in malignant pleural mesothelioma evaluation and management. The Oncologist. September 2014;19(9):975-84. doi: 10.1634/theoncologist.2014-0122
Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients. Oncoimmunology. August 2014;2(8):e26218. doi: 10.4161/onci.26218
Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. Journal of Clinical Oncology. July 2012;30(20):2509-15. doi: 10.1200/JCO.2011.41.5869
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy. Clinical Cancer Research. August 2016;22(15):3791-800. doi: 10.1158/1078-0432.CCR-15-2133
The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma. OncoTargets and Therapy. November 2016;9:7247-7252. doi: 10.2147/OTT.S100214
Dr. Stevenson’s Accolades
Throughout his career, Dr. Stevenson has been recognized by his patients and the medical community. Dr. Stevenson’s accolades demonstrate the value he brings to the mesothelioma field.
- Certification in Medical Oncology – American Board of Internal Medicine
- Best Regional Doctors – Castle Connolly
- Philadelphia Magazine Award – Philadelphia Magazine